Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...
TEMPO.CO, Jakarta - Tim peneliti dari Badan Riset dan Inovasi Nasional (BRIN) menunjukkan kemajuan dalam pengembangan obat untuk penyakit menular seperti tuberkulosis (TB) dan malaria. Project ...
Researchers analyzed global trends in multidrug-resistant tuberculosis (MDR-TB) among children and adolescents, revealing ...
Multidrug-resistant TB (MDR-TB) is a type of tuberculosis caused by strains resistant to rifampicin and isoniazid. In 2022, around 410,000 people worldwide developed MDR or rifampicin-resistant TB ...